Niki BioSolutions, Inc. (NIKI) Form 10-Q Quarterly Reports
Niki BioSolutions, Inc. (NIKI) is a publicly traded company on the Nasdaq, categorized under SIC 3829 (Measuring & Controlling Devices, NEC). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NIKI
CIK: 1734005
Exchange: Nasdaq
SIC 3829: Measuring & Controlling Devices, NEC
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Marcum Asia CPAs LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJieheng He
Audit LocationGuangzhou, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-3/A | 2026-10-02 | — | PRE-EFFECTIVE AMENDMENT NO. 3 TO FORM S-3 | 0001213900-26-106480 | View SEC Doc Filr Page |
| S-3/A | 2026-09-18 | — | PRE-EFFECTIVE AMENDMENT 2 TO FORM S-3 | 0001213900-26-101473 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | CURRENT REPORT | 0001213900-26-099695 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-04 | CURRENT REPORT | 0001213900-26-097705 | View SEC Doc Filr Page |
| RW | 2026-08-28 | — | WITHDRAWAL REQUEST | 0001213900-26-095189 | View SEC Doc Filr Page |
| S-3 | 2026-08-28 | — | REGISTRATION STATEMENT | 0001213900-26-094595 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-21 | 2026-07-20 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-092689 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | CURRENT REPORT | 0001213900-26-092661 | View SEC Doc Filr Page |
| 3 | 2026-08-13 | 2026-07-20 | 3 Filing | 0001213900-26-089063 | View SEC Doc Filr Page |
| 3 | 2026-08-13 | 2026-07-20 | 3 Filing | 0001213900-26-088803 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | CURRENT REPORT | 0001213900-26-086639 | View SEC Doc Filr Page |
| 3 | 2026-07-28 | 2026-07-20 | 3 Filing | 0001213900-26-082351 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-24 | — | SCHEDULE 13D Filing | 0001213900-26-081416 | View SEC Doc Filr Page |
| 3 | 2026-07-24 | 2026-07-20 | 3 Filing | 0001213900-26-081412 | View SEC Doc Filr Page |
| 3 | 2026-07-24 | 2026-07-20 | 3 Filing | 0001213900-26-081408 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | CURRENT REPORT | 0001213900-26-079416 | View SEC Doc Filr Page |
| 6-K/A | 2026-06-22 | 2026-06-22 | AMENDMENT NO. 1 TO FORM 6-K | 0001213900-26-070672 | View SEC Doc Filr Page |
| 6-K | 2026-06-10 | 2026-06-10 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-067085 | View SEC Doc Filr Page |
| 424B3 | 2026-06-04 | — | PROSPECTUS | 0001213900-26-065316 | View SEC Doc Filr Page |
| EFFECT | 2026-06-03 | — | EFFECT Filing | 9999999995-26-001862 | View SEC Doc Filr Page |
| POS AM | 2026-05-29 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-26-062284 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2025-12-31 | CURRENT REPORT | 0001213900-26-056820 | View SEC Doc Filr Page |
| EFFECT | 2026-05-13 | — | EFFECT Filing | 9999999995-26-001605 | View SEC Doc Filr Page |
| S-4/A | 2026-05-11 | — | REGISTRATION STATEMENT | 0001213900-26-054062 | View SEC Doc Filr Page |
| S-4/A | 2026-04-30 | — | REGISTRATION STATEMENT | 0001213900-26-050304 | View SEC Doc Filr Page |